SleepCited

Melatonin Natural Health Products and Supplements: Presence of Serotonin and Significant Variability of Melatonin Content.

Lauren A E Erland, Praveen K Saxena
Other Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2017 226 件の引用

研究デザイン

研究タイプ
Observational Study
サンプルサイズ
31
対象集団
30 commercial melatonin supplement brands/forms (31 total samples) analyzed by UPLC
介入
Melatonin Natural Health Products and Supplements: Presence of Serotonin and Significant Variability of Melatonin Content.
比較対照
Labelled content claim
主要アウトカム
Melatonin content accuracy vs label claim and presence of serotonin in commercial supplements
効果の方向
Negative
バイアスリスク
Low

抄録

STUDY OBJECTIVES: Melatonin is an important neurohormone, which mediates circadian rhythms and the sleep cycle. As such, it is a popular and readily available supplement for the treatment and prevention of sleep-related disorders including insomnia and jet lag. This study quantified melatonin in 30 commercial supplements, comprising different brands and forms and screened supplements for the presence of serotonin. METHODS: A total of 31 supplements were analyzed by ultraperformance liquid chromatography with electrochemical detection for quantification of melatonin and serotonin. Presence of serotonin was confirmed through analysis by ultraperformance liquid chromatography with mass spectrometry detection. RESULTS: Melatonin content was found to range from -83% to +478% of the labelled content. Additionally, lot-to-lot variable within a particular product varied by as much as 465%. This variability did not appear to be correlated with manufacturer or product type. Furthermore, serotonin (5-hydroxytryptamine), a related indoleamine and controlled substance used in the treatment of several neurological disorders, was identified in eight of the supplements at levels of 1 to 75 μg. CONCLUSIONS: Melatonin content did not meet label within a 10% margin of the label claim in more than 71% of supplements and an additional 26% were found to contain serotonin. It is important that clinicians and patients have confidence in the quality of supplements used in the treatment of sleep disorders. To address this, manufacturers require increased controls to ensure melatonin supplements meet both their label claim, and also are free from contaminants, such as serotonin. COMMENTARY: A commentary on this article appears in this issue on page 163.

要約

Melatonin content did not meet label within a 10% margin of the label claim in more than 71% of supplements and an additional 26% were found to contain serotonin, a controlled substance used in the treatment of several neurological disorders.

エビデンスレビューでの引用